[Lyme borreliosis]

Internist (Berl). 2003 Feb;44(2):175-6, 179-82. doi: 10.1007/s00108-002-0770-y.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Autoimmune Diseases / diagnosis*
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / microbiology
  • Borrelia burgdorferi / immunology
  • Borrelia burgdorferi / pathogenicity*
  • Borrelia burgdorferi Group / immunology
  • Borrelia burgdorferi Group / pathogenicity*
  • Child
  • Humans
  • Lyme Disease / diagnosis*
  • Lyme Disease / drug therapy
  • Lyme Disease / immunology
  • Lyme Disease / microbiology
  • Lyme Neuroborreliosis / diagnosis
  • Lyme Neuroborreliosis / drug therapy
  • Lyme Neuroborreliosis / immunology
  • Lyme Neuroborreliosis / microbiology
  • Molecular Mimicry / immunology
  • Virulence

Substances

  • Anti-Bacterial Agents